THY1 and Alzheimer disease: To date, only one study investigated the effect of young plasma on AD-related pathologies and cognition in APP mice that express mutant human APP (isoform 751) bearing both the Swedish (K670N/M671L) and the London (V717I) mutations under the control of the murine thy1 promoter [26].